Improving Pharmacological Transition of Palliative Care Patients From Inpatient to Outpatient Care
Recruiting now · Not applicable
Conditions studied: Cancer, Heart Failure, COPD
In brief
The transition of palliative care patients from inpatient to outpatient care is aimed to be improved through structured pharmaceutical discharge management by a trained pharmacist. This data will be compared with retrospective cases.
Key facts
- Study ID
- NCT06648733
- Run by
- University Hospital Muenster
- People needed
- 200
- Starts
- 2024-06-20
- Expected to finish
- 2025-12-31
- Last updated by the study team
- 2025-06-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All individual indications for general and specialised palliative care as part of routine clinical practice (e.g.):
- advanced, malignant tumour disease
- advanced, chronic obstructive pulmonary disease
- Patients with advanced disease and limited life expectancy (approx. 12 months) Further care in the SOPC Muenster (prospective data) Sufficient understanding of the German language to be able to understand the information and consent form
You may not qualify if…
- Impossibility of understanding the information and declaration of consent.
Where it is running
- University Hospital Muenster — Münster, North Rhine-Westphalia, Germany (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.